{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T11:26:57Z","timestamp":1793014017221,"version":"4.5.0"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"40","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,26]]},"DOI":"10.1093\/eurheartj\/ehag551","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T11:37:43Z","timestamp":1784029063000},"page":"6036-6038","source":"Crossref","is-referenced-by-count":1,"title":["Lowering cumulative LDL-C exposure: the case for early treatment"],"prefix":"10.1093","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7397-6520","authenticated-orcid":false,"given":"Archna","family":"Bajaj","sequence":"first","affiliation":[{"name":"Division of Translational Medicine and Human Genetics, Perelman School of Medicine, University of Pennsylvania , Philadelphia, PA 19104 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6808-3824","authenticated-orcid":false,"given":"Marina","family":"Cuchel","sequence":"additional","affiliation":[{"name":"Division of Translational Medicine and Human Genetics, Perelman School of Medicine, University of Pennsylvania , Philadelphia, PA 19104 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"key":"2026102519522432500_ehag551-B1","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"key":"2026102519522432500_ehag551-B2","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41569-024-01039-5","article-title":"The LDL cumulative exposure hypothesis: evidence and practical applications","volume":"21","author":"Ference","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"2026102519522432500_ehag551-B3","doi-asserted-by":"publisher","first-page":"4359","DOI":"10.1093\/eurheartj\/ehaf190","article-title":"2025 Focused Update of the 2019 ESC\/EAS Guidelines for the management of dyslipidaemias","volume":"46","author":"Mach","year":"2025","journal-title":"Eur Heart J"},{"key":"2026102519522432500_ehag551-B4","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1016\/j.jacc.2025.11.016","article-title":"2026 ACC\/AHA\/AACVPR\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of dyslipidemia: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"87","author":"Blumenthal","year":"2026","journal-title":"J Am Coll Cardiol"},{"key":"2026102519522432500_ehag551-B5","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.1093\/eurheartj\/ehag382","article-title":"Familial hypercholesterolaemia in children andadolescents: a European Atherosclerosis Societyconsensus statement","volume":"47","author":"Wiegman","year":"2026","journal-title":"Eur Heart J"},{"key":"2026102519522432500_ehag551-B6","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur Heart J"},{"key":"2026102519522432500_ehag551-B7","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1161\/CIRCULATIONAHA.119.044795","article-title":"Prevalence of familial hypercholesterolemia among the general population and patients with atherosclerotic cardiovascular disease: a systematic review and meta-analysis","volume":"141","author":"Hu","year":"2020","journal-title":"Circulation"},{"key":"2026102519522432500_ehag551-B8","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1016\/j.jacc.2020.03.057","article-title":"Worldwide prevalence of familial hypercholesterolemia: meta-analyses of 11 million subjects","volume":"75","author":"Beheshti","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026102519522432500_ehag551-B9","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.038458","article-title":"Life course approach for managing familial hypercholesterolemia","volume":"14","author":"Gidding","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"2026102519522432500_ehag551-B10","doi-asserted-by":"publisher","first-page":"6021","DOI":"10.1093\/eurheartj\/ehag349","article-title":"Cholesterol-lowering therapy from childhood\/adolescence and long-term outcomes in familial hypercholesterolaemia: the SAFEHEART study","volume":"47","author":"Vallejo-Vaz","year":"2026","journal-title":"Eur Heart J"},{"key":"2026102519522432500_ehag551-B11","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/NEJMoa1816454","article-title":"20-year follow-up of statins in children with familial hypercholesterolemia","volume":"381","author":"Luirink","year":"2019","journal-title":"N Engl J Med"},{"key":"2026102519522432500_ehag551-B12","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/j.jacc.2023.07.028","article-title":"Childhood screening for familial hypercholesterolemia: JACC review topic of the week","volume":"82","author":"Gidding","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2026102519522432500_ehag551-B13","doi-asserted-by":"publisher","first-page":"118598","DOI":"10.1016\/j.atherosclerosis.2024.118598","article-title":"Efficacy and safety of statins, ezetimibe and statins\u2013ezetimibe therapies for children and adolescents with heterozygous familial hypercholesterolaemia: systematic review, pairwise and network meta-analyses of randomised controlled trials","volume":"401","author":"Llewellyn","year":"2025","journal-title":"Atherosclerosis"},{"key":"2026102519522432500_ehag551-B14","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s11883-020-00881-5","article-title":"Women living with familial hypercholesterolemia: challenges and considerations surrounding their care","volume":"22","author":"Balla","year":"2020","journal-title":"Curr Atheroscler Rep"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/47\/40\/6036\/70799646\/ehag551.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/47\/40\/6036\/70799646\/ehag551.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T23:52:27Z","timestamp":1792972347000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/47\/40\/6036\/8771060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":14,"journal-issue":{"issue":"40","published-online":{"date-parts":[[2026,8,26]]},"published-print":{"date-parts":[[2026,10,26]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehag551","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10,21]]},"published":{"date-parts":[[2026,8,26]]}}}